Information profile @ a Glance
- Laboratory diagnosis plays an important role in disease and outbreak
management. Fast and
accurate laboratory diagnosis of a specific viral infection of interest
contributes to prompt
public health surveillance, prevention, and control measures
- According to the Johns Hopkins Center for Health Security,
diagnostic testing for COVID-19 is mainly undertaken through the use of
two approaches:
1.whole genome sequencing and real-time reverse transcriptase PCR (rRT-PCR).
Genome
sequencing was used primarily early in the outbreak to facilitate
initial identification
of the virus. Current diagnostic testing for COVID-19 is mostly done
using rRT-PCR.
2.Prior to the Chinese authorities’ decision on 12 February to expand
the diagnosis criteria for COVID-19 to include clinicallydiagnosed cases, nucleic acid testing (NAT) or RNA tests through the
rRT-PCR process
was the primary diagnostic tool.
- The Department of Health Research (DHR) / Indian Council of Medical
Research (ICMR) initiated establishment of a network of public health
laboratories to enhance capacity for diagnosis and detection of viruses
of public health importance in India
- Following the increase in load of screening samples from suspected
cases with symptoms and travel history to the affected countries, DHR/ICMR
has commissioned 51 laboratories for COVID-19 testing in India In addition, NCDC Delhi is also engaged in testing. (Total = 57
laboratories) All these laboratories have an operational Real-Time PCR
platform
- The protocols for diagnostics using RT-PCR published on WHO’s
webpage is for guidance and not an exhaustive list. Various institutions
and governments have
chosen to develop their own protocols that might not be publicly
available or published by
WHO on their webpage.
- The Indian Council of Medical Research (ICMR) has approved 176 labs,
including 47 private labs, to conduct the tests
- The first test kit that received FDA approval, the Cobas SARS CoV-2
kit from Roche, is also approved in India. The second, the TaqPath
COVID-19 Combo Kit from Thermo Fisher, is in the process of getting
validated by the ICMR labs.
- As long as proper certification and training are in place, any
accredited lab using the WHO/CDC suggested protocols can yield
satisfactory results.
|
Basics
- Corona Virus Break
- Therapeutics for treatment
of COVID-19 and the clinical trials in progress.
- Vaccine Development
- New Developments
Institutional Support
- Interim guidance to laboratories
and stakeholders involved in COVID-19 virus laboratory testing
of patients.
- Interim Guidance
- World association of Labs
- Training Resources
Regulations
- Lab Approval authority
- Approval Requirment
- Fact sheet - FDA
- Guidance document for State Nodal & Testing
VRDLs for COVID-19
- COVID-19 Guidance on Sample Collection
and Testing
- Testing in Private Labs in India
- List of COVID 19 Testing
Laboratories - India
Project Information
- Business Opportunity
- Emergency Response
Project
- Commercial Testing
- Diagnostics, Test Kits, therapeutics &
Clinical Trials
- Laboratory diagnosis
- Automatically detect COVID‐19
pneumonia patients using digital x‐ray images
- Reverse Transcription-Loop-Mediated
Isothermal Amplification
- Serology testing for COVID-19
Containment Measures
- Multi-intervention
Strategies
- Rapid Detection and
Point-of-Care Diagnostics
- Rapid Testing
- Single test on multiple
patients
Global Scenario
- USA - Lab
- USA Lab - Texas
- USA - California
- Laboratory Preparedness in India
- U.K
- Covid-19: What is the UK’s testing
strategy?
- India Scenario
- Bangla desh
- Sri Lanka
Order the database to day |